Volume 90 Issue 3 | p. 19 | Concentrates
Issue Date: January 16, 2012

Biotech Firms Make Job Cuts

Department: Business
Keywords: pharmaceuticals, employment, biopharmaceuticals

Human Genome Sciences will eliminate 150 jobs, or about 14% of its workforce, to better address its drug R&D and business needs. The cutbacks will affect manufacturing, R&D, and administrative areas. By the end of this quarter, Xoma will lay off 34% of its staff, or 84 positions, to focus on its lead product, gevokizumab. Most of the reductions stem from Xoma’s decision to outsource late-stage and commercial manufacturing and some research. The drug delivery firm SkyePharma is looking to cut about 20% of the 101 employees it has in Muttenz, Switzerland. The company will lease lab space to Aenova, which already leases SkyePharma’s drug product manufacturing site in France.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment